MediWound Ltd. SEC filings MDWD
MediWound Ltd. has 397 filings in SEC EDGAR's recent list, going back to Dec 23, 2013. Its latest annual report, Form 20-F, was filed on Mar 5, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 5, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Mar 27, 2025 | — |
| CORRESP | Letter to the SEC | Mar 25, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 24, 2025 | — |
| EFFECT | Filing | Sep 9, 2024 | — |
| CORRESP | Letter to the SEC | Sep 5, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 5, 2024 | — |
| EFFECT | Filing | Apr 5, 2023 | — |
| POS EX | Filing | Mar 16, 2023 | — |
| EFFECT | Filing | Nov 25, 2022 | — |
| CORRESP | Letter to the SEC | Nov 22, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 16, 2022 | — |
| D | Filing | Oct 6, 2022 | — |
| D | Filing | Oct 4, 2022 | — |
| EFFECT | Filing | Jun 3, 2022 | — |
| CORRESP | Letter to the SEC | Jun 1, 2022 | — |
| UPLOAD | Letter from the SEC | May 31, 2022 | — |
| EFFECT | Filing | Apr 22, 2019 | — |
| CORRESP | Letter to the SEC | Apr 18, 2019 | — |
| CORRESP | Letter to the SEC | Apr 12, 2019 | — |
| CT ORDER | Filing | Apr 9, 2019 | — |
| UPLOAD | Letter from the SEC | Apr 8, 2019 | — |
| CT ORDER | Filing | Mar 20, 2017 | — |
| CT ORDER | Filing | Feb 28, 2017 | — |
| EFFECT | Filing | Mar 7, 2016 | — |
| CORRESP | Letter to the SEC | Mar 3, 2016 | — |
| CORRESP | Letter to the SEC | Feb 29, 2016 | — |
| CORRESP | Letter to the SEC | Feb 24, 2016 | — |
| UPLOAD | Letter from the SEC | Feb 16, 2016 | — |
| CT ORDER | Filing | Feb 11, 2016 | — |
| CT ORDER | Filing | Mar 20, 2014 | — |
| EFFECT | Filing | Mar 19, 2014 | — |
| CERTNAS | Auto-generated paper document | Mar 19, 2014 | — |
| CORRESP | Letter to the SEC | Mar 17, 2014 | — |
| 8-A12B | Filing | Mar 12, 2014 | — |
| UPLOAD | Letter from the SEC | Mar 7, 2014 | — |
| CORRESP | Letter to the SEC | Feb 18, 2014 | — |
| UPLOAD | Letter from the SEC | Feb 12, 2014 | — |
| CORRESP | Letter to the SEC | Jan 31, 2014 | — |
| DRS/A | Filing | Jan 31, 2014 | — |
| DRS/A | Filing | Jan 27, 2014 | — |
| UPLOAD | Letter from the SEC | Jan 16, 2014 | — |
| DRS/A | Filing | Jan 15, 2014 | — |
| DRS | Filing | Dec 23, 2013 | — |
Showing 43 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- MDWD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Yavne, Israel
- SEC filer status
- Accelerated filer
- SEC CIK
- 1593984
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.